(Q38469433)

3 September 2017

title

Noble metals strip peptides from class II MHC proteins (English)

1 reference

3 September 2017

Stephen L De Wall

1

1 reference

3 September 2017

Corrie Painter

2

1 reference

3 September 2017

Jennifer D Stone

3

1 reference

3 September 2017

Rajintha Bandaranayake

4

1 reference

3 September 2017

Don C Wiley

5

1 reference

3 September 2017

Timothy J Mitchison

6

1 reference

3 September 2017

Lawrence J Stern

7

1 reference

3 September 2017

Brian S DeDecker

8

1 reference

3 September 2017

publication date

26 February 2006

1 reference

3 September 2017

published in

Nature Chemical Biology

1 reference

3 September 2017

volume

2

1 reference

3 September 2017

issue

4

1 reference

3 September 2017

page(s)

197-201

1 reference

Inhibition of Thermus thermophilus HB8 thioredoxin activity by platinum(II).

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO773

Reactions of gold(III) ions with ribonuclease A and methionine derivatives in aqueous solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO773

Identification of T cell ligands in a library of peptides covalently attached to HLA-DR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO773

Capture and processing of exogenous antigens for presentation on MHC molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO773

7 January 2021

Allosteric drugs: thinking outside the active-site box.

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO773

7 January 2021

An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO773

7 January 2021

Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO773

7 January 2021

Novel Adducts of the Anticancer Drug Oxaliplatin with Glutathione and Redox Reactions with Glutathione Disulfide

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO773

7 January 2021

Ligand substitution reactions at inorganic centers

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO773

7 January 2021

The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO773

7 January 2021

DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO773

7 January 2021

Monoclonal antibodies specific for the empty conformation of HLA-DR1 reveal aspects of the conformational change associated with peptide binding

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO773

7 January 2021

Identification of the lateral interaction surfaces of human histocompatibility leukocyte antigen (HLA)-DM with HLA-DR1 by formation of tethered complexes that present enhanced HLA-DM catalysis

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO773

7 January 2021

https://api.crossref.org/works/10.1038%2FNCHEMBIO773

1 reference

7 January 2021

Drug-induced inhibition of insulin recognition by T-cells: the antirheumatic drug aurothiomalate inhibits MHC binding of insulin peptide

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO773

7 January 2021

Phagocytes render chemicals immunogenic: oxidation of gold(I) to the T cell-sensitizing gold(III) metabolite generated by mononuclear phagocytes

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO773

7 January 2021

Redox Chemistry and [Au(CN)(2)] in the Formation of Gold Metabolites

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO773

7 January 2021

Alteration of a model antigen by Au(III) leads to T cell sensitization to cryptic peptides

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO773

7 January 2021

Gold-specific T cells in rheumatoid arthritis patients treated with gold

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO773

7 January 2021

Activation of gold-reactive T lymphocytes in rheumatoid arthritis patients treated with gold

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO773

7 January 2021

Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO773

7 January 2021

Immunomodulatory effects of therapeutic gold compounds. Gold sodium thiomalate inhibits the activity of T cell protein kinase C

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO773

7 January 2021

Cis-dichlorodiammineplatinum (II): suppression of adjuvant-induced arthritis in rats

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO773

7 January 2021

cis-platinum, a treatment for refractory rheumatoid arthritis?

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO773

7 January 2021

Have traditional DMARDs had their day? Effectiveness of parenteral gold compared to biologic agents

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO773

7 January 2021

Metal complexes as enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO773

7 January 2021

Identifiers

DOI

10.1038/NCHEMBIO773

1 reference

Dimensions Publication ID

3 September 2017

1006821974

0 references

1 reference